| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000038497 |
| Receipt No. | R000043834 |
| Scientific Title | Investigation of postoperative nutritional management for dialysis patients undergoing digestive surgery and the association between the timing of starting oral intake after surgery and the outcome: A cohort study using DPC database |
| Date of disclosure of the study information | 2019/12/05 |
| Last modified on | 2020/04/14 (Ver. 8) |
| Basic information | ||
| Public title | Investigation of postoperative nutritional management for dialysis patients undergoing digestive surgery and the association between the timing of starting oral intake after surgery and the outcome: A cohort study using DPC database
|
|
| Acronym | The postoperative nutritional management for dialysis patients undergoing digestive surgery | |
| Scientific Title | Investigation of postoperative nutritional management for dialysis patients undergoing digestive surgery and the association between the timing of starting oral intake after surgery and the outcome: A cohort study using DPC database
|
|
| Scientific Title:Acronym | The postoperative nutritional management for dialysis patients undergoing digestive surgery | |
| Region |
|
|
| Condition | |||||
| Condition | Dialysis patients who underwent digestive resection | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Malignancy | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | In dialysis patients who underwent digestive resection,
(1) to clarify the clinical practice of postoperative nutrition management (2) to investigate the association between the timing of starting oral intake after surgery and the outcome |
| Basic objectives2 | Others |
| Basic objectives -Others | Survey |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Postoperative complications within 30 days after surgery
(anastomotic leakage, surgical site infection, pneumonia, urinary tract infection, catheter infection ) |
| Key secondary outcomes | - Mortality in a hospital
- Mortality within 30 days after surgery - Worsening of ADL at discharge - Rehospitalization within 30 days after discharge - Length of postoperative hospital stay - 15-day postoperative hospital stay - Controlling nutritional status at discharge |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Patients aged 18 years or older who underwent any of the following digestive resection surgeries from January 1, 2009 to December 31,2018
1) Esophageal surgery 2) Stomach surgery 3) Biliary and gallbladder surgery 4) Liver surgery 5) Pancreatic surgery 6) Small intestine surgery 7) Colon surgery 8) Rectal surgery (2) Patients who have records of dialysis conducted one week before surgery and within 30 days after surgery |
|||
| Key exclusion criteria | (1) Patients who have no body weight data
(2) Patients whose height is less than 100cm or 200cm or more (3) Patients whose body weight is less than 10kg or 200kg or more (4) Patients who died within 7 days after surgery (5) Patients who were discharged within 7 days after surgery (6) Patients who underwent emergency surgery |
|||
| Target sample size | 4000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Osaka Prefectural Hospital Organization
Osaka International Cancer Institute |
||||||
| Division name | Nutritional Oncology | ||||||
| Zip code | 541-8567 | ||||||
| Address | 3-1-69 Otemae, Chuo-ku, Osaka city, Osaka | ||||||
| TEL | 06-6945-1181 | ||||||
| Shohei.iijima@oici.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Otsuka Pharmaceutical Factory, Inc. | ||||||
| Division name | Applied Clinical Development Department | ||||||
| Zip code | 101-0048 | ||||||
| Address | 2-9 Kanda Tsukasamachi, Chiyoda-ku Tokyo | ||||||
| TEL | 03-5217-5954 | ||||||
| Homepage URL | |||||||
| Tani.Miyuki@otsuka.jp | |||||||
| Sponsor | |
| Institute | Otsuka Pharmaceutical Factory, Inc.
|
| Institute | |
| Department | |
| Funding Source | |
| Organization | Otsuka Pharmaceutical Factory, Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Osaka Prefectural Hospital Organization
Osaka International Cancer Institute |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Osaka Prefectural Hospital Organization Osaka International Cancer Institute |
| Address | 3-1-69 Otemae, Chuo-ku, Osaka city, Osaka |
| Tel | 06-6945-1181 |
| rinri01@opho.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Study design
A cohort study using the medical database Data source A medical database provided by Medical Data Vision Co. Ltd. The database is based on the DPC data/medical and technical service claims data. The database covers about 20% of all DPC hospitals in Japan. All data is anonymized from the viewpoint of personal information protection. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043834 |